The SARS-CoV-2 pandemic and the urgent need for massive antiviral testing highlighted the lack of a good cell-based assay that allowed for a fast, automated screening of antivirals in high-throughput content with minimal handling requirements in a BSL-3 environment. The present paper describes the construction of a green fluorescent substrate that, upon cleavage by the SARS-CoV-2 main protease, re-localizes from the cytoplasm in non-infected cells to the nucleus in infected cells. The construction was stably expressed, together with a red fluorescent nuclear marker, in a highly susceptible clone derived from Vero-81 cells. With this fluorescent reporter cell line, named F1G-red, SARS-CoV-2 infection can be scored automatically in living cel...
The coronavirus SARS-CoV-2 causes the severe disease COVID-19. SARS-CoV-2 infection is initiated by ...
Our therapeutic arsenal against viruses is very limited and the current pandemic of SARS-CoV-2 highl...
Virus infections in siRNA-based cellular protein knockdowns - imaging dataset for cell viability Hos...
International audienceThe SARS-CoV-2 pandemic and the urgent need for massive antiviral testing high...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the acute...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the acute...
Funder: NIHR Cambridge BRCEfforts to define serological correlates of protection against COVID-19 ha...
The emergence of the SARS-CoV-2 virus and the exponential growth of COVID-19 cases have created a ma...
International audienceOur therapeutic arsenal against viruses is very limited and the current pandem...
Research activities with infectious severe acute respiratory syndrome associated coronavirus 2 (SARS...
We have engineered a cell that can be used for diagnosing active severe acute respiratory syndrome c...
The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-...
The coronavirus SARS-CoV-2 causes the severe disease COVID-19. SARS-CoV-2 infection is initiated by ...
Our therapeutic arsenal against viruses is very limited and the current pandemic of SARS-CoV-2 highl...
Virus infections in siRNA-based cellular protein knockdowns - imaging dataset for cell viability Hos...
International audienceThe SARS-CoV-2 pandemic and the urgent need for massive antiviral testing high...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the acute...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the acute...
Funder: NIHR Cambridge BRCEfforts to define serological correlates of protection against COVID-19 ha...
The emergence of the SARS-CoV-2 virus and the exponential growth of COVID-19 cases have created a ma...
International audienceOur therapeutic arsenal against viruses is very limited and the current pandem...
Research activities with infectious severe acute respiratory syndrome associated coronavirus 2 (SARS...
We have engineered a cell that can be used for diagnosing active severe acute respiratory syndrome c...
The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-...
The coronavirus SARS-CoV-2 causes the severe disease COVID-19. SARS-CoV-2 infection is initiated by ...
Our therapeutic arsenal against viruses is very limited and the current pandemic of SARS-CoV-2 highl...
Virus infections in siRNA-based cellular protein knockdowns - imaging dataset for cell viability Hos...